Health
BioNTech Stock Pops Ahead Of Earnings; But Can Its Vaccine Tackle Delta? – Investor’s Business Daily
BioNTech stock popped Monday after the Covid-vaccine maker said it would announce second-quarter earnings results in a week.
BioNTech stock popped Monday after the Covid vaccine maker said it would announce second-quarter earnings results in a week.
XAnalysts polled by FactSet expect BioNTech (BNTX) to report adjusted earnings of $8.94 per share and almost $3.86 billion in sales….
Continue Reading
-
Noosa News14 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
Noosa News23 hours agoNT cattle rustler fined almost $430k for stealing 116 head from neighbouring station
-
Business23 hours agoRevenue growth, profit margin pressures, and a $365m buyback
-
Noosa News22 hours agoThe wait to taste new Queensland-grown purple-skinned pineapples